Column

In this column for Axios, Drew Altman discusses a new poll finding showing substantial support for Republicans to drop repeal and work with Democrats on improving the Affordable Care Act, from the general public, Trump supporters, and Republicans.

In this Axios column, Drew Altman explains that as Republican policymakers are focused on delivering a repeal of Obamacare for their base, polling shows that it’s not a top priority for Trump supporters, and their intensity on a replacement plan has declined, suggesting that the issue may not drive turnout for future elections.

In a Washington Post op-ed, Drew Altman dissects the difference between the talking points and the reality of the Senate health bill to replace the Affordable Care Act and change Medicaid.

In this New York Times op-ed, “The Republicans’ Jekyll-and-Hyde Health Care Plan,” Drew Altman examines the Senate health plan.

In his Axios column, Drew Altman examines how the core views Republicans have about Medicaid differ from those of Democrats and Independents, and how those views drive the policy changes they are proposing for the program.

In this Axios column, Drew Altman highlights that the federal debate about the American Health Care Act’s Medicaid spending reductions will ultimately be a debate about every state’s general budget spending priorities, as states discuss whether to offset reductions in federal revenues with some combination of cuts to their Medicaid programs, increased taxes, and cuts to spending in other areas.

In this Axios column, Drew Altman lays out how the “political pain” from the American Health Care Act would play out over the next two election cycles if passed in its current form, based on the Congressional Budget Office’s analysis of the House-passed bill.

With Medicaid about to be a focal point of debate in the Senate, Drew Altman’s Axios column looks at why the idea that the program is broken is more urban legend than fact.

In this Axios column, Drew Altman analyzes new poll findings which show how one issue breaks through the gridlock between Democrats and Republicans in health – the high cost of prescription drugs.

In this column as an Axios contributor, Drew Altman discusses President Trump’s threat to withhold cost sharing subsidies and questions whether his approach to deal making can bridge health care’s partisan and ideological divide. “Health policy is not like real estate,” he says.